Article ID Journal Published Year Pages File Type
9321434 European Urology Supplements 2005 6 Pages PDF
Abstract
LHRH agonists have been thought to achieve an almost 100% of response in the initial therapy. Several studies have shown that when using a more stringent definition of castration, treatment with current LHRH agonists does not achieve this goal. As a consequence, measurement of testosterone should regain attention for evaluating treatment response to LHRH agonists as well as for monitoring breakthroughs and acute-on-chronic responses.
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Authors
,